[HTML][HTML] Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
Infections with Neisseria meningitidis and Neisseria gonorrhoeae have different clinical
manifestations, but the bacteria share up to 80–90% genome sequence identity. The …
manifestations, but the bacteria share up to 80–90% genome sequence identity. The …
[HTML][HTML] Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination
F Martinón-Torres, A Banzhoff, C Azzari, P De Wals… - Journal of Infection, 2021 - Elsevier
Objectives 4CMenB is a broadly protective vaccine against invasive meningococcal
capsular group B disease (MenB IMD). Licensed worldwide based on immunogenicity and …
capsular group B disease (MenB IMD). Licensed worldwide based on immunogenicity and …
Acceptability of a gonococcal vaccine among sexually active men who have sex with men
WE Abara, RD Kirkcaldy, KT Bernstein… - Sexually transmitted …, 2022 - journals.lww.com
Background Prospects for a gonococcal vaccine have advanced. Vaccine acceptability is
crucial to maximizing population-level protection among key groups, such as men who have …
crucial to maximizing population-level protection among key groups, such as men who have …
[HTML][HTML] Avances recientes en la prevención de la enfermedad meningocócica B: evidencia real de la vacunación con 4CMenB
F Martinón-Torres, A Banzhoff, C Azzari, P de Wals… - Vacunas, 2021 - Elsevier
Objetivos 4CMenB es una vacuna que confiere protección frente a la enfermedad
meningocócica invasiva por el serogrupo B (EMI por MenB). Autorizada en todo el mundo a …
meningocócica invasiva por el serogrupo B (EMI por MenB). Autorizada en todo el mundo a …
[HTML][HTML] Recent advances in the prevention of meningococcal B disease: real evidence from 4CMenB vaccination
F Martinón-Torres, A Banzhoff, C Azzari… - Vacunas (English …, 2021 - Elsevier
Abstract Objectives The 4CMenB vaccine confers protection against serogroup B invasive
meningococcal disease (MenB IMD). Licensed worldwide based on immunogenicity and …
meningococcal disease (MenB IMD). Licensed worldwide based on immunogenicity and …